Bath emollients have ‘no benefit beyond standard eczema care for children’

Bath emollients have ‘no benefit beyond standard eczema care for children’

May 9 2018 A study has found no evidence of clinical benefit from including bath emollients in...

Cochrane: honey rated better for children’s cough than some OTC preps or placebo

Cochrane: honey rated better for children’s cough than some OTC preps or placebo

April 16 2018 Honey appears likely to help children’s cough more than diphenhydramine, a...

OTC Viagra Connect availability to widen following launch via Boots

OTC Viagra Connect availability to widen following launch via Boots

April 11 2018 Viagra Connect should be available from most pharmacies at the end of this week,...

MHRA issues warning over flammability of headlice treatments

MHRA issues warning over flammability of headlice treatments

March 9 2018 Pharmacists have been asked to tell customers about the risk of fire when discussing...

OTC industry proposes maximum level for vitamin D in food supplements

OTC industry proposes maximum level for vitamin D in food supplements

March 6 2018 Food supplement manufacturers are proposing to set the maximum dose of vitamin D at...

  • Bath emollients have ‘no benefit beyond standard eczema care for children’

    Bath emollients have ‘no benefit beyond standard eczema care for children’

    Wednesday, 09 May 2018 15:28
  • Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Monday, 16 April 2018 09:13
  • OTC Viagra Connect availability to widen following launch via Boots

    OTC Viagra Connect availability to widen following launch via Boots

    Wednesday, 11 April 2018 12:52
  • MHRA issues warning over flammability of headlice treatments

    MHRA issues warning over flammability of headlice treatments

    Friday, 09 March 2018 16:15
  • OTC industry proposes maximum level for vitamin D in food supplements

    OTC industry proposes maximum level for vitamin D in food supplements

    Tuesday, 06 March 2018 12:24

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a pharmacist woman consultSeptember 4 2017

Boots has announced it is starting to make available a cheaper generic levonorgestrel product for its emergency hormonal contraception service. It means it can offer the EHC service at a cost of £15.99.

 The announcement follows criticism some months ago about the price it charged, when competitors were reducing prices by not using branded medicines. Boots has now issued a statement saying: “We have listened to our customers’ feedback and we committed to sourcing a less expensive EHC medicine to enable us to make a privately funded EHC service more accessible in the future.

“We can confirm that four weeks ago we started the roll out of this service to 38 stores and have been offering it with a new, less expensive generic version of EHC (levonorgestrel) at a cost of £15.99; which reflects the cost of the medicine and the regulated mandatory consultation with the pharmacist.”

The company added that it has been working with the manufacturer to increase supply with the intention of being able to offer the generic medicine across all stores from October. “We wanted to be assured of supply and a roll out date before confirming this publicly,” it said.

“Boots will offer the generic version of levonorgestrel alongside Ella One, Levonelle and Boots Pharmaceuticals (Levonelle) options to ensure we can provide a range of solutions that are right depending on a woman’s individual circumstances and according to the guidance from the Faculty of Sexual and Reproductive Healthcare.”

Link:
Boots statement               

OTC News

May 23 2018 The Court of Appeal has commenced hearing a case around the Government’s cut in pharmacy funding and other changes to community pharmacy introduced in 2016.
May 21 2018  NHS England and Capita’s handling of primary care support services has been criticised in an official report. The National Audit Office has published a review saying that “NHS England and...